Dear Well-wishers,

I take immense pleasure in reaching out to you through this May 2016 edition of Oviya MedSafe’s newsletter which synopsizes our contemporary active involvement in a range of initiatives, of course within our beloved pharmacovigilance domain!

The first half of May 2016 was indeed invigorating with a great sense of responsibility on my shoulders as a Program Committee Member of the DIA conference ‘Innovations in Pharmacovigilance – the era of e-PV‘, especially as the Moderator of the panel discussion titled ‘Destination India – Pharmacovigilance Outsourcing‘ with eminent colleagues from the industry as panelists. I also had the opportunity to provide my insights on the overall agenda of the conference, which were well-received by my fellow members in the Program Committee, the Conference Chair, the Conference Vice Chair and staff of DIA India. The conference was a grand success and I personally received appreciations from many of the professionals in the audience. Please click here to watch my brief video interview recorded during the conference.

This DIA conference was an eye-opener for me to comprehend the far & wide reach of brand Oviya MedSafe and realize the trust placed on us by our colleagues in the pharmaceutical and the CRO industries not only in India but outside the country too. Specifically, the acclaim that many of the delegates had for our monthly newsletters, especially the April 2016 edition titled ‘Oviya MedSafe excels in Pharmacovigilance of Patient Support Programmes & Market Research Programmes‘ was of tremendous gratification to our passionate commitment to pharmacovigilance beyond business.

Although the habit of publishing papers is not new to me or my colleagues at Oviya MedSafe, it was one of my greatest honours to have co-authored an article titled ‘Pharmacovigilantes in the Pharmacovigilance Programme of India (PvPI): Ideal Qualities and Skills‘ with Dr G N Singh (Drug Controller General of India), Dr V Kalaiselvan (Principal Scientific Officer, Indian Pharmacopoeia Commission) and Dr Thota Prasad (Scientific Assistant, Indian Pharmacopoeia Commission). This article was published in the April 2016 edition of the Journal of Young Pharmacists and the full-text-PDF is available for download from the title link above. I wish to thank PvPI for having given me this prestigious opportunity and look forward to hearing your feedback on the article.

While speaking of PvPI, it is relevant to mention that the forthcoming Indian Pharmacovigilance Day 2016 Conference to be held at Peninsula Grand Hotel, Mumbai on Friday 29-July-2016 is all set to analyze and decipher the various perspectives of Drug Safety from an Indian point of view. As the Chair of the conference, I am delighted to announce that the conference agenda has been updated in the concerned section of the event website and shall continue to be updated during the following week. At this juncture, it is my duty to heartily thank all the renowned invited speakers who have honoured my invitation and confirmed their participation in the conference. I am quite confident that, with all the experts on the dais and the agenda covering a range of topics pertinent to the domain of Pharmacovigilance in India, the event will be the first of its kind and cherished forever by the delegates and speakers alike as a conference that was worth attending and well conducted.

Last but not the least; I would fail in my duty if I do not thank Italy-based EasyB srl, the organizers of the ‘Pharmacovigilance Day’ series of conferences, for having announced a 25% discount as Early Bird Fees for all categories of registrations for the Indian Pharmacovigilance Day 2016, until 30-Jun-2016. Please visit the conference website or contact the organizers at +917598815311 or for registrations or more information.

Looking forward to meeting you with our June 2016 news,

With thanks & regards,
Dr J Vijay Venkatraman

Managing Director & CEO,
Oviya MedSafe Pvt Ltd,
Coimbatore, India
Phone: +91-422-2444442

Oviya MedSafe UK Ltd,
London, UK
Phone: +44-8452-733839

Follow us on: FacebookGoogle PlusLinkedIn & Twitter

Leave a comment

Your email address will not be published. Required fields are marked *